scholarly journals Dupilumab Maintains Long-Term Disease Control in Adults with Moderate-to-Severe Atopic Dermatitis as Measured by Well-Controlled Weeks: Results From the LIBERTY AD CHRONOS Clinical Trial

2021 ◽  
Author(s):  
Jashin J. Wu ◽  
Lynda Spelman ◽  
Jerry L. Tan ◽  
Takafumi Etoh ◽  
Haixin Zhang ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Atopic Dermatitis ◽  
Disease Control ◽  
Severe Atopic Dermatitis

scholarly journals Long-Term Safety and Disease Control With Ruxolitinib Cream in Patients With More Severe Atopic Dermatitis: Pooled Results From Two Phase 3 Studies

2021 ◽  
Vol 5 (6) ◽  
pp. s66
Author(s):  
Eric Simpson ◽  
Leon Kircik ◽  
Andrew Blauvelt ◽  
Michael Kuligowski ◽  
May Venturanza ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Disease Control ◽  
Severe Atopic Dermatitis ◽  
Phase 3 ◽  
Two Phase

N/A

scholarly journals 129 Extent and consequences of inadequate disease control among adults with a history of moderate-to-severe atopic dermatitis

2016 ◽  
Vol 136 (5) ◽  
pp. S23 ◽  
Author(s):  
W. Wei ◽  
P. Anderson ◽  
A. Gadkari ◽  
S. Blackburn ◽  
R. Moon ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Disease Control ◽  
Severe Atopic Dermatitis ◽  
History Of

scholarly journals Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study

2018 ◽  
Vol 142 (4) ◽  
pp. 1121-1130.e7 ◽  
Author(s):  
Kenji Kabashima ◽  
Masutaka Furue ◽  
Jon M. Hanifin ◽  
Grazyna Pulka ◽  
Andreas Wollenberg ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Phase Ii ◽  
Extension Study ◽  
Severe Atopic Dermatitis ◽  
Randomized Phase Ii
Sign in / Sign up

Export Citation Format

Share Document